Correction of Malocclusion by Botulinum Neurotoxin Injection into Masticatory Muscles [PDF]
Hyun Seok, Seong‐Gon Kim
openalex +1 more source
Reduction in Post-Botulinum Toxin Flu-like Symptoms After Injection with Incobotulinum Toxin [PDF]
OBJECTIVE: To determine if patients reporting flu-like symptoms (FLS) after botulinum toxin (BoNT) injections are less susceptible to this reaction after incobotulinum toxin.
George, Edwin, Shneyder, Natalya
core +1 more source
Video Urodynamic Study in Patients with Parkinson's Disease and Multiple System Atrophy
Abstract Background Most studies have analyzed the urodynamic characteristics of patients with Parkinson's disease (PD) and multiple system atrophy (MSA) using conventional urodynamic studies. Objectives This study investigated the urodynamic characteristics of both diseases using video urodynamic study (VUDS).
Hyun Sik Yoon +3 more
wiley +1 more source
Botulinum neurotoxin (BoNT) is produced by the bacterium Clostridium botulinum and some other bacterial strains such as C. butyricum and C. baratii. It is considered the strongest toxin known to humans and can cause botulism.
Ninh Thi Hanh +5 more
doaj +1 more source
Amylase release from streptolysin O-permeabilized pancreatic acinar cells. Effects of Ca2+, guanosine 5'-[gamma-thio]triphosphate, cyclic AMP, tetanus toxin and botulinum A toxin [PDF]
The molecular requirements for amylase release and the intracellular effects of botulinum A toxin and tetanus toxin on amylase release were investigated using rat pancreatic acinar cells permeabilized with streptolysin O.
Ahnert-Hilger, G. +4 more
core
A Systematic Review of the Parkinson's Foundation Hospital Care Recommendations
Abstract Background People with Parkinson's disease (PwP) face increased risks of complications and longer hospital stays compared to the general population. Four major factors contribute to increased morbidity and mortality during hospitalization: medication timing errors, administration of harmful medications, restricted mobility, and dysphagia ...
Ariane Veilleux Carpentier +12 more
wiley +1 more source
Paradoxical bulging of muscle after injection of botulinum neurotoxin type A into hypertrophied masseter muscle [PDF]
Sang Ju Lee +4 more
openalex +1 more source
Reply to “Neurophysiological Testing to Diagnose Stiff‐Person Spectrum Disorder”
Movement Disorders Clinical Practice, Volume 13, Issue 1, Page 303-304, January 2026.
João Moura +5 more
wiley +1 more source
This study demonstrated significant treatment efficacy and safety of incobotulinumtoxinA injection in Japanese patients with chronic sialorrhea caused by Parkinson's disease and other neurological conditions. Suppression of salivary secretion and improvement in drooling symptoms were also observed throughout 48 weeks.
Nobutaka Hattori +15 more
wiley +1 more source
Deep Brain Stimulation for Focal or Segmental Craniocervical Dystonia in Patients Who Have Failed Botulinum Neurotoxin Therapy—A Narrative Review of the Literature [PDF]
Thorsten Odorfer, Jens Volkmann
openalex +1 more source

